XpertPatient
XpertPatient is a free, web-based oncology education platform serving newly diagnosed cancer patients, caregivers, and healthcare providers with personalized, plain-language diagnosis information and side-by-side FDA-approved treatment comparisons across 14 cancer types, monetized via pharmaceutical and healthcare brand sponsorships.
- Company typePrivate
- Founded2021
- HeadquartersChatham, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What XpertPatient does
XpertPatient (XpertPatient LLC, Chatham, NJ) is a privately held oncology education platform founded in 2021 by Risa L. Arin, a two-time cancer caregiver and patient advocate. The web-based platform delivers personalized, plain-language cancer diagnosis and treatment information to newly diagnosed patients, caregivers, and healthcare providers across 14 cancer types — covering approximately 90% of U.S. cancer diagnoses. Core products include the proprietary "Compare My Treatment Options" tool (side-by-side evaluation of FDA-approved treatments by cancer type and stage, including administration, side effects, and payment assistance), the "Create My Conversation Guide" question-preparation tool, the Financial Support Directory, a Best Cancer Hospitals directory, and ChatGPT-powered Q&A. Content is curated from Cancer.gov and NCCN Guidelines and refined for accessibility by a medical team led by a Medical Oncologist (Dr. Lenora Valdez) and a Hematology/Oncology Nurse Practitioner (Ines Stefania Mancia).
The underlying technology combines a curated structured content database with a third-party OpenAI ChatGPT integration for natural-language Q&A and an Antidote clinical-trial search embed. The company has not disclosed proprietary AI models, patents, or in-house ML infrastructure. The platform is free to patients and caregivers with no account requirement, designed as a self-serve direct-to-consumer tool that personalizes the experience by cancer type, stage, and user role (patient, caregiver, HCP, other).
The business model is advertising- and sponsorship-driven rather than consumer-paid. Revenue comes exclusively from premium sponsorships sold to pharmaceutical companies, cancer centers, and healthcare brands seeking targeted access to high-intent patients throughout the cancer education journey. Distribution is primarily through organic search and direct website traffic (xpertpatient.com), with go-to-market support from strategic partners including the Global Cancer Institute, CancerCare, Patient Empowerment Network, and St. John's Riverside Hospital. The company has not disclosed external funding, operates with 1–10 employees, and has been recognized with multiple industry awards (Digital Health Awards 2023–2024, Stevie American Business Awards 2023, PM360 Most Innovative Healthcare Startups 2022).
XpertPatient firmographics
Firmographics- Name
- XpertPatient
- Legal name
- XpertPatient LLC
- Website
- https://xpertpatient.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- XpertPatient is a free, web-based oncology education platform serving newly diagnosed cancer patients, caregivers, and healthcare providers with personalized, plain-language diagnosis information and side-by-side FDA-approved treatment comparisons across 14 cancer types, monetized via pharmaceutical and healthcare brand sponsorships.
- Ownership category
- akta.pro rank
XpertPatient industry classification
Industry- Product category
- Patient Education Software
- NAICS
- All Other Outpatient Care Centers (621498)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
- akta.pro secondary industry
- Oncology Telemedicine Platforms (HLALAGAH)
Keywords
Where XpertPatient is headquartered
LocationHeadquarters
- HQ city
- Chatham
- HQ country
- United States
- HQ region
- North America
Markets served
XpertPatient business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Premium Sponsorships: Pharmaceutical companies and healthcare brands can sponsor the platform to reach their target audience throughout the patient's personalized cancer education experience. The company describes this as 'no-waste premium sponsorships' with advanced audience targeting capabilities.
- Cancer Center Sponsorship: Targeted sponsorship opportunities for cancer centers looking to reach engaged patients and caregivers on the platform.
- Content Sponsorships: Sponsored content allows pharmaceutical companies to bring support to patients, appearing throughout the user's personalized cancer education journey.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free access for patients and caregivers |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
XpertPatient product offering
Product offeringCore offering
XpertPatient operates a cancer patient education platform that delivers personalized, easy-to-understand diagnosis information and side-by-side treatment comparisons for 14 major cancer types. The platform curates content from Cancer.gov and NCCN Guidelines, integrates a ChatGPT-powered Q&A feature, and connects patients to financial support resources and top cancer hospitals. The company monetizes primarily through premium sponsorships sold to pharmaceutical companies and healthcare brands.
Product overview
XpertPatient is a cancer patient education platform built as a unified web application offering personalized, easy-to-understand diagnosis information and treatment comparisons. The core platform centers on the Compare My Treatment Options tool, which enables side-by-side comparison of FDA-approved treatments by cancer type and stage sourced from Cancer.gov and NCCN Guidelines. Key modules include the Financial Support Directory (connecting patients with payment assistance from drug manufacturers and non-profits), the Best Cancer Hospitals Directory (NCI-designated centers), and Cancer Type Video Libraries. The platform covers 14 cancer types including breast, prostate, lung, pancreatic, colorectal, bladder, kidney, liver, melanoma, leukemia, and lymphoma. Additional features include the Create My Conversation Guide (question preparation for oncologists), ChatGPT-powered Q&A for common patient questions, and the XPFuel monthly newsletter. Content is curated from Cancer.gov and NCCN Guidelines and refined for patient accessibility.
Differentiator
Problem solved
Functional benefit
Products and services
- XpertPatient Platform Cancer patient education platform that personalizes diagnosis information and treatment comparisons across 14 cancer types, integrating content from Cancer.gov and NCCN Guidelines for newly diagnosed patients and caregivers.
- Compare My Treatment Options Tool Side-by-side comparison tool that lets patients and caregivers compare FDA-approved cancer treatments by cancer type and stage, including how treatments are administered, side effects, and payment assistance options.
- Financial Support Directory Resource directory connecting cancer patients with payment assistance programs from drug manufacturers, non-profit organizations, and Medicare coverage information for cancer treatments.
- Premium Sponsorship Packages Audience-targeted sponsorship placements (no-waste premium sponsorships) for pharmaceutical companies and healthcare brands to reach newly diagnosed cancer patients and caregivers throughout a personalized cancer education journey, including cancer center and content sponsorship packages.
Quantifiable outcome
- Better patient outcomes: Research shows that people who take an active role in their health experience better health outcomes
- +3 more outcomes
Companies that use XpertPatient
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
XpertPatient technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature4 records
XpertPatient partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Global Cancer InstitutecoreGlobal Cancer Institute collaborates with XpertPatient to deliver unbiased treatment information and discussion guides that help patients have better conversations with their care providers. Carolyn Ricci, former Executive Director of Global Cancer Institute, serves as Strategic Advisor and Advocacy Liaison for XpertPatient.
- St. John's Riverside HospitalcoreOncology Patient Services Manager Shari Rosenberg collaborates with XpertPatient's Customer Experience Team to ensure content reflects urgent needs of families on a cancer journey. Her insights help shape patient-centered services and resources.
- National Institute of Oncology JaliscocoreDr. Lenora Valdez, Medical Oncologist and Solid Tumor Specialist, leads XpertPatient's medical content team to deliver complex cancer-related content into easy-to-understand terms. She ensures content is medically accurate, up-to-date, and 100% patient-centric.
- CancerCarecoreCancerCare is featured on XpertPatient as a recommended resource for cancer patients seeking financial assistance, counseling, and support services. The partnership helps connect patients with payment help for treatment and daily living expenses.
- Patient Empowerment NetworkminorAndrea Conners, Executive Director of Patient Empowerment Network, provides endorsements for XpertPatient's Conversation Guide feature, highlighting its value in improving patient care through asking the right questions.
- Terese Winslow LLCminorListed as a sponsor contributing to XpertPatient's mission of advancing cancer patient education.
- Go CrayonsminorListed as a sponsor contributing to XpertPatient's mission of advancing cancer patient education.
- Memorres DigitalminorDigital partner that teamed up with XpertPatient to help cancer patients. Listed as a collaborator on patient education mission.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
XpertPatient competitors and assessment
Company assessmentDirect peers
- Patient Empowerment Network: Cancer-focused patient education and empowerment organization that endorses XpertPatient's Conversation Guide feature. Highly comparable mission and content categories around shared decision-making.
- Healthline: One of the largest consumer health information publishers, monetized via advertising and brand partnerships. Directly comparable to XpertPatient's editorial + sponsorship model and notably employs XpertPatient's CRO Joe Petrosino, who previously led Healthline.
- CancerCare: Nonprofit providing free counseling, financial assistance, and educational resources to cancer patients. An existing XpertPatient referral partner, indicating directly overlapping patient services and content scope.
- Sharecare: Digital health company combining consumer health content, wellness tools, and condition-specific education programs. Competes for newly diagnosed patient engagement and pharma-sponsored content opportunities.
- WebMD: Dominant consumer health information platform with deep pharma sponsorship relationships and oncology content verticals. Competes for the same newly diagnosed patient search intent and pharma sponsorship dollars as XpertPatient.
Others
- National Cancer Institute (Cancer.gov): The authoritative U.S. government source of cancer information and the very source of XpertPatient's curated content. Defines the baseline of free, trusted cancer information against which XpertPatient must differentiate.
- Antidote: Clinical trial matching platform already integrated into XpertPatient's platform. Adjacent enabling technology for oncology patient engagement and a potential expansion vector.
Broad incumbents
- Outcome Health: Healthcare advertising platform connecting pharma brands with patients and HCPs across digital endpoints. Comparable business model of monetizing engaged health audiences via pharma sponsorship inventory.
- American Cancer Society: The largest nonprofit cancer support and patient education organization in the U.S. Provides free cancer information, treatment resources, and financial assistance — directly overlapping XpertPatient's patient education and financial support directories.
- PatientPoint: Larger point-of-care health education and patient engagement platform monetized through pharma and health-system sponsorships. A scaled analog of XpertPatient's pharma sponsorship GTM in a different care setting.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
XpertPatient social profiles
Digital presenceXpertPatient financial estimates
Financial estimateRevenue estimate
Valuation estimate
XpertPatient leadership team
Management profileNumber of profiles
Profiles7 records
XpertPatient funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
XpertPatient M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about XpertPatient
What does XpertPatient do?
XpertPatient operates a cancer patient education platform that delivers personalized, easy-to-understand diagnosis information and side-by-side treatment comparisons for 14 major cancer types. The platform curates content from Cancer.gov and NCCN Guidelines, integrates a ChatGPT-powered Q&A feature, and connects patients to financial support resources and top cancer hospitals. The company monetizes primarily through premium sponsorships sold to pharmaceutical companies and healthcare brands.
Is XpertPatient a public or private company?
XpertPatient is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was XpertPatient founded?
XpertPatient was founded in 2021. It employs 1 to 10 people.
Where is XpertPatient based?
XpertPatient is headquartered in Chatham, United States, in the North America region.
How does XpertPatient make money?
Three revenue lines are on record. Premium Sponsorships are the primary driver. The others are cancer Center Sponsorship and content Sponsorships.
Who are XpertPatient's main competitors?
Direct peers on record are Patient Empowerment Network, Healthline, CancerCare, Sharecare and WebMD. Others are National Cancer Institute (Cancer.gov) and Antidote. Broad incumbents are Outcome Health, American Cancer Society and PatientPoint.
Does XpertPatient have an API?
No public API is recorded for XpertPatient.
What industry is XpertPatient in?
XpertPatient's product category is Patient Education Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 621498 and its SIC code is 8000.